Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
Allogeneic transplantation
FM100 regimen
Haploidentical transplantation
Hodgkin lymphoma
Melphalan conditioning
Non-Hodgkin lymphoma
Journal
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
26
09
2018
accepted:
04
02
2019
pubmed:
15
2
2019
medline:
2
7
2020
entrez:
15
2
2019
Statut:
ppublish
Résumé
We analyzed 186 patients with lymphoma who underwent allogeneic stem cell transplantation (ASCT) with fludarabine-melphalan (FM) conditioning and different types of donors (25 haploidentical [HD], 98 matched unrelated [MUD], and 63 matched related [MRD]) at our institution between September 2009 and January 2018. Patients received fludarabine 160 mg/m
Identifiants
pubmed: 30763728
pii: S1083-8791(19)30097-7
doi: 10.1016/j.bbmt.2019.02.002
pmc: PMC8265611
mid: NIHMS1585860
pii:
doi:
Substances chimiques
Vidarabine
FA2DM6879K
fludarabine
P2K93U8740
Melphalan
Q41OR9510P
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1340-1346Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Références
Biol Blood Marrow Transplant. 2018 Jun;24(6):1237-1242
pubmed: 29378303
N Engl J Med. 2018 Jul 5;379(1):64-73
pubmed: 29972754
N Engl J Med. 2018 Jan 25;378(4):331-344
pubmed: 29224502
Bone Marrow Transplant. 2018 Sep;53(9):1139-1148
pubmed: 29540849
Biol Blood Marrow Transplant. 2007 Apr;13(4):454-62
pubmed: 17382251
Blood. 2001 Feb 1;97(3):631-7
pubmed: 11157478
Bone Marrow Transplant. 2003 Apr;31(8):667-78
pubmed: 12692607
Blood. 2016 Feb 18;127(7):938-47
pubmed: 26670632
Biol Blood Marrow Transplant. 2016 Nov;22(11):2047-2055
pubmed: 27522040
Bone Marrow Transplant. 2017 Jun;52(6):811-817
pubmed: 28287639
Biol Blood Marrow Transplant. 2013 Mar;19(3):344-56
pubmed: 22922522
Biol Blood Marrow Transplant. 2016 Mar;22(3):493-8
pubmed: 26497906
J Hematol Oncol. 2017 Jun 12;10(1):117
pubmed: 28606176
J Clin Oncol. 2017 Oct 20;35(30):3425-3432
pubmed: 28846465
Nat Rev Clin Oncol. 2018 Aug;15(8):510-527
pubmed: 29777163
Cancer. 2018 Apr 15;124(8):1733-1742
pubmed: 29424927
J Clin Oncol. 2016 Sep 10;34(26):3141-9
pubmed: 27269951
Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11):655-63
pubmed: 26428486
Cancer. 2016 Nov 15;122(21):3316-3326
pubmed: 27404668
J Clin Oncol. 2013 Apr 1;31(10):1310-6
pubmed: 23423745
Biol Blood Marrow Transplant. 2016 Sep;22(9):1543-1551
pubmed: 27131863
Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50
pubmed: 18489989
Biol Blood Marrow Transplant. 2008 Nov;14(11):1279-87
pubmed: 18940683
Bone Marrow Transplant. 2016 Jul;51(7):949-54
pubmed: 26999464
Biol Blood Marrow Transplant. 2013 Oct;19(10):1453-8
pubmed: 23872222